Experience

Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders…

Davis Polk advised Advanced Semiconductor Engineering, Inc. in connection with an SEC-registered rights offering of 240,000,000 common shares. The offering raised gross proceeds of…

Davis Polk advised the initial purchasers of a Regulation S offering of high-yield notes by China Evergrande Group of $1 billion aggregate principal amount of its 9.50% senior notes due…

Davis Polk advised Heineken N.V. on its offering of $1.1 billion aggregate principal amount of its 3.50% senior notes due 2028 and $650 million aggregate principal amount of its 4.35%…

Davis Polk advised Sumitomo Mitsui Financial Group, Inc. on its debut SEC-registered takedown offering of Australian dollar-denominated senior TLAC notes, which consisted of AUD300 million…

Davis Polk advised the underwriters in connection with an SEC-registered offering of $1.5 billion aggregate principal amount of 3.150% fixed-rate senior debt securities, $1.5 billion…

Davis Polk advised Tencent in connection with its acquisition of 5% of Tesla’s common stock for approximately $1.8 billion. Tencent is one of China’s largest and most widely used Internet…

Davis Polk advised the underwriters in connection with an SEC-registered secondary offering of 5,000,000 common shares of Orion Engineered Carbons S.A. by Kinove Luxembourg Holdings 1 S.à r…

Davis Polk advised the representatives of the underwriters in connection with the $75.9 million offering of 3,700,000 shares of common stock of REGENXBIO Inc. The common stock is listed on…

Davis Polk advised Grupo Unicomer Co. Ltd. in connection with its Rule 144A/Regulation S offering of $350 million aggregate principal amount of its 7.875% senior notes due 2024. The notes…